A novel functionally selective drug for the treatment of cocaine abuse by antagonism of the beta-arrestin signaling arm of the Ghrelin Receptor
Research Grant
Administered By
Basic Science Departments
Awarded By
National Institutes of Health
Start Date
September 30, 2020
End Date
March 29, 2022
Administered By
Basic Science Departments
Awarded By
National Institutes of Health
Start Date
September 30, 2020
End Date
March 29, 2022